Gastrointestinal Disorder, Functional
8
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
85.7%
-0.8% vs benchmark
13%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness
Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study
Therapeutic Effect of Olive Leaf Tea on SIBO
Analysis of the Impact of Used Probiotic Strains and Diet on Body Composition, Cardiopulmonary Efficiency and the Incidence of Gastrointestinal Disorders in Runners
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
PHAGE Study: Bacteriophages as Novel Prebiotics
Impact of Diet on Functional Gastrointestinal Symptoms
Effect of Oat Bran on Bowel Function and Appetite